Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons-Reference-Cited by-同舟云学术

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons

Published:2004-07 Issue:2 Volume:16 Page:428-439
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Kishima Haruhiko,Poyot Thomas,Bloch Jocelyne,Dauguet Julien,Condé Françoise,Dollé Frédéric,Hinnen Françoise,Pralong William,Palfi Stéphane,Déglon Nicole,Aebischer Patrick,Hantraye Philippe

Publisher

Elsevier BV

Subject

Neurology

Reference53 articles.

1. Performance evaluation of the whole-body PET scanner ECAT EXACT HR+ following the IEC standard;Adam;IEEE Trans. Nucl. Sci.,1997

2. Gene therapy approaches for Parkinson's disease;Aebischer;J. Neurochem.,2003

3. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients;Aebischer;Nat. Med.,1996

4. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF;Bachoud-Levi;Hum. Gene Ther.,2000

5. Comparison of ketmine with the combination of ketamine and xylazine for effective anesthesia in the rhesus monkey (Macaca mulatta);Banknieder;Lab. Anim. Sci.,1978

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric Nanocarriers for the Delivery of Phytoconstituents;Nanotechnology Based Delivery of Phytoconstituents and Cosmeceuticals;2024

2. Cell Encapsulation and 3D Bioprinting for Therapeutic Cell Transplantation;ACS Biomaterials Science & Engineering;2023-03-06

3. Sustainable green synthesized nanoparticles for neurodegenerative diseases diagnosis and treatment;Materials Today: Proceedings;2023

4. Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders;Materials;2022-01-21

5. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease;Molecular and Cellular Neuroscience;2022-01